Related references
Note: Only part of the references are listed.Super-Enhancer-Associated Long Noncoding RNA HCCL5 Is Activated by ZEB1 and Promotes the Malignancy of Hepatocellular Carcinoma
Li Peng et al.
CANCER RESEARCH (2019)
TERT structural rearrangements in metastatic pheochromocytomas
Trisha Dwight et al.
ENDOCRINE-RELATED CANCER (2018)
Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomas
De-Chen Lin et al.
GUT (2018)
Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling
Stephen C. Mack et al.
NATURE (2018)
Super-enhancers define a proliferative PGC-1α-expressing melanoma subgroup sensitive to BET inhibition
K. A. Gelato et al.
ONCOGENE (2018)
TBX4 is involved in the super-enhancer-driven transcriptional programs underlying features specific to lung fibroblasts
Masafumi Horie et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors
Jaclyn Andricovich et al.
CANCER CELL (2018)
E6 Protein Expressed by High-Risk HPV Activates Super-Enhancers of the EGFR and c-MET Oncogenes by Destabilizing the Histone
Xiaohua Chen et al.
CANCER RESEARCH (2018)
Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma
Jian-Jun Xie et al.
GASTROENTEROLOGY (2018)
Luminal lncRNAs Regulation by ER-Controlled Enhancers in a Ligand-Independent Manner in Breast Cancer Cells
Valentina Miano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
MLL4 Is Required to Maintain Broad H3K4me3 Peaks and Super-Enhancers at Tumor Suppressor Genes
Shilpa S. Dhar et al.
MOLECULAR CELL (2018)
The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML
Daniel Gerlach et al.
ONCOGENE (2018)
MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma
Marielle E. Yohe et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory axis in proliferation
Veronica Garcia-Carpizo et al.
EPIGENETICS & CHROMATIN (2018)
Stratification of TAD boundaries reveals preferential insulation of super-enhancers by strong boundaries
Yixiao Gong et al.
NATURE COMMUNICATIONS (2018)
HPV integration hijacks and multimerizes a cellular enhancer to generate a viral-cellular super-enhancer that drives high viral oncogene expression
Alix Warburton et al.
PLOS GENETICS (2018)
LMO1 super-enhancer polymorphism rs2168101 G>T correlates with decreased neuroblastoma risk in Chinese children
Jing He et al.
JOURNAL OF CANCER (2018)
Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia
Christopher J. Ott et al.
CANCER CELL (2018)
BRD4 and Cancer: going beyond transcriptional regulation
Benedetta Donati et al.
MOLECULAR CANCER (2018)
TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
Bieke Decaesteker et al.
NATURE COMMUNICATIONS (2018)
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
Jingyi Liu et al.
NATURE COMMUNICATIONS (2018)
CDK7 inhibition is a novel therapeutic strategy against GBM both in vitro and in vivo
Wei Meng et al.
CANCER MANAGEMENT AND RESEARCH (2018)
BET Family Protein BRD4: An Emerging Actor in NFκB Signaling in Inflammation and Cancer
Azadeh Hajmirza et al.
BIOMEDICINES (2018)
Targeting Super-Enhancers for Disease Treatment and Diagnosis
Ha Youn Shin
MOLECULES AND CELLS (2018)
Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma
Yan-Yi Jiang et al.
GUT (2017)
Aberrant activation of the GIMAP enhancer by oncogenic transcription factors in T-cell acute lymphoblastic leukemia
W-S Liau et al.
LEUKEMIA (2017)
SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation
Xiaofeng Wang et al.
NATURE GENETICS (2017)
Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking
Joachim Weischenfeldt et al.
NATURE GENETICS (2017)
A novel LSD1 inhibitor NCD38 ameliorates MDS-related leukemia with complex karyotype by attenuating leukemia programs via activating super-enhancers
N. Sugino et al.
LEUKEMIA (2017)
Expanding the effects of ERG on chromatin landscapes and dysregulated transcription in prostate cancer
Deepak Babu et al.
NATURE GENETICS (2017)
A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers
Dominik Glodzik et al.
NATURE GENETICS (2017)
Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis
Liangru Ke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer
Paola A. Betancur et al.
NATURE COMMUNICATIONS (2017)
The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma
Jiyuan Zhang et al.
CANCER DISCOVERY (2017)
Mice deficient of Myc super-enhancer region reveal differential control mechanism between normal and pathological growth
Kashyap Dave et al.
ELIFE (2017)
Mediator Kinase Phosphorylation of STAT1 S727 Promotes Growth of Neoplasms With JAK-STAT Activation
Ioana I. Nitulescu et al.
EBIOMEDICINE (2017)
Epigenetic and genetic dissections of UV-induced global gene dysregulation in skin cells through multi-omics analyses
Yao Shen et al.
SCIENTIFIC REPORTS (2017)
Super-Enhancers and Broad H3K4me3 Domains Form Complex Gene Regulatory Circuits Involving Chromatin Interactions
Fan Cao et al.
SCIENTIFIC REPORTS (2017)
Long Noncoding RNA Linc00152 Functions as a Tumor Propellant in Pan-Cancer
Shouping Xu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma
Jiang Yuan et al.
CANCER RESEARCH (2017)
Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET Inhibitors
Jennifer M. Sahni et al.
CANCER RESEARCH (2017)
The Epstein-Barr Virus Regulome in Lymphoblastoid Cells
Sizun Jiang et al.
CELL HOST & MICROBE (2017)
Targeting of super-enhancers and mutant BRAF can suppress growth of BRAF-mutant colon cancer cells via repression of MAPK signaling pathway
Yoshiaki Nakamura et al.
CANCER LETTERS (2017)
Transcriptional circuits in B cell transformation
Yeguang Hu et al.
CURRENT OPINION IN HEMATOLOGY (2017)
Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival
Casey D. S. Katerndahl et al.
NATURE IMMUNOLOGY (2017)
CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors
Yijie Ma et al.
CELL HOST & MICROBE (2017)
Super-Enhancer-Driven Transcriptional Dependencies in Cancer
Satyaki Sengupta et al.
TRENDS IN CANCER (2017)
Epigenomic landscape of 5-hydroxymethylcytosine reveals its transcriptional regulation of lncRNAs in colorectal cancer
Hanyang Hu et al.
BRITISH JOURNAL OF CANCER (2017)
Transcriptional Addiction in Cancer
James E. Bradner et al.
CELL (2017)
Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition
Anton Henssen et al.
CLINICAL CANCER RESEARCH (2016)
Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors
R. Gopalakrishnan et al.
ONCOGENE (2016)
A Druggable TCF4-and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm
Michele Ceribelli et al.
CANCER CELL (2016)
Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells
Lars Togel et al.
MOLECULAR CANCER THERAPEUTICS (2016)
An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma
Yotam Drier et al.
NATURE GENETICS (2016)
RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth
Andrea Gunnell et al.
NUCLEIC ACIDS RESEARCH (2016)
Tandemly Integrated HPV16 Can Form a Brd4-Dependent Super-Enhancer-Like Element That Drives Transcription of Viral Oncogenes
Katharine E. Dooley et al.
MBIO (2016)
5-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patients
Kevin C. Johnson et al.
NATURE COMMUNICATIONS (2016)
NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation
Veronica Garcia-Carpizo et al.
SCIENTIFIC REPORTS (2016)
Genetic Predisposition to Chronic Lymphocytic Leukemia Is Mediated by a BMF Super-Enhancer Polymorphism
Radhika Kandaswamy et al.
CELL REPORTS (2016)
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
Celine Berthon et al.
LANCET HAEMATOLOGY (2016)
Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study
Sandy Amorim et al.
LANCET HAEMATOLOGY (2016)
CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer
Yubao Wang et al.
CELL (2015)
Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium
Sharon E. Johnatty et al.
CLINICAL CANCER RESEARCH (2015)
THZ1 Reveals Roles for Cdk7 in Co-transcriptional Capping and Pausing
Kyle A. Nilson et al.
MOLECULAR CELL (2015)
Mediator kinase inhibition further activates super-enhancer-associated genes in AML
Henry E. Pelish et al.
NATURE (2015)
TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors
Linda J. Valentijn et al.
NATURE GENETICS (2015)
Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes
Kaifu Chen et al.
NATURE GENETICS (2015)
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
Van T. M. Nguyen et al.
NATURE COMMUNICATIONS (2015)
Somatic Cell Fusions Reveal Extensive Heterogeneity in Basal-like Breast Cancer
Ying Su et al.
CELL REPORTS (2015)
ETS family transcriptional regulators drive chromatin dynamics and malignancy in squamous cell carcinomas
Hanseul Yang et al.
ELIFE (2015)
Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case
Birgit Knoechel et al.
COLD SPRING HARBOR MOLECULAR CASE STUDIES (2015)
CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer
Edmond Chipumuro et al.
CELL (2014)
Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus
Jian-Feng Xiang et al.
CELL RESEARCH (2014)
Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia
M. A. Dawson et al.
LEUKEMIA (2014)
Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma
Paul A. Northcott et al.
NATURE (2014)
Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
Nicholas Kwiatkowski et al.
NATURE (2014)
A NOTCH 1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia
Daniel Herranz et al.
NATURE MEDICINE (2014)
EGFR Variant Heterogeneity in Glioblastoma Resolved through Single-Nucleus Sequencing
Joshua M. Francis et al.
CANCER DISCOVERY (2014)
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Jakob Loven et al.
CELL (2013)
Super-Enhancers in the Control of Cell Identity and Disease
Denes Hnisz et al.
CELL (2013)
Functional and Mechanistic Diversity of Distal Transcription Enhancers
Michael Bulger et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson et al.
NATURE (2011)
Long-range chromatin regulatory interactions in vivo
D Carter et al.
NATURE GENETICS (2002)